Business

Novo Nordisk Strikes Major Licensing Deal

Updated 2026-09-25 09:25 UTC 1 source Positive

Novo Nordisk, the Danish drug giant, struck a licensing deal worth over $1 billion just days after its capital-markets day left investors uncertain about its future.

Coverage timeline — 1 article

MarketWatch

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.

2026-09-25 09:11 UTC